Antibiotic susceptibility and biofilm pattern in Staphylococcus aureus from clinical sources in Diyala Governorate
DOI:
https://doi.org/10.24237/04.02.591Keywords:
Antibiotic susceptibility, biofilm formation, Staphylococcus aureusAbstract
Staphylococcus aureus is a pathogenic bacteria that causes a variety of diseases, from skin infections to serious and fatal infections, due to producing a variety of virulence factors. Biofilm is the most important virulence factors that confers S. aureus the severity. This study aims to isolate S. aureus from different sites of the human body and investigate the distribution of antibiotic resistance and biofilm profiles and the relationship between them. In this study, 250 clinical specimens were collected from teaching laboratories in Baqubah Teaching Hospital, Diyala Province, Iraq, from which, fifty isolates were selected to conduct this study. Based on morphological and biochemical tests, the isolates were identified, and the VITEK2 system confirmed the identities of the isolates. The isolates were tested with 12 antibiotics belong to different groups. The isolates showed high resistance to Oxacillin (100%), azithromycin (68%). In contrast, a high susceptibility percentage was observed with nitrofurantoin (84%), chloramphenicol (90%), rifampin (76%), gentamicin (68%), clindamycin (70%), tetracycline (48%), norfloxacin (62%), trimethoprim-sulfamethoxazole (60%), levofloxacin (62%), and ciprofloxacin (60%). The biofilm formation test revealed that 22(44%) of S. aureus isolates were strong biofilm-forming, 26(52%) were moderate, and 2(4%) were weak biofilm-forming. This study revealed a correlation between the isolates with strong biofilm and their antibiotic resistance pattern. In conclusion, these recent results may provide a basis to treat S. aureus by developing new antibiotics.
Downloads
References
1. M. Pal, G. B. Kerorsa, L. M. Marami, and V. Kandi, "Epidemiology, pathogenicity, animal infections, antibiotic resistance, public health significance, and economic impact of staphylococcus aureus: a comprehensive review," American Journal of Public Health Research, vol. 8, no. 1, pp. 14-21, 2020. doi:10.12691/ajphr-8-1-3.
2. M. Idrees, S. Sawant, N. Karodia, and A. Rahman, "Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies," International Journal of Environmental Research and Public Health, vol. 18, no. 14, p. 7602, 2021. doi: 10.3390/ijerph18147602.
3. A. Abou Fayad et al., "Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significance," BMJ Global Health, vol. 7, no. Suppl 8, p. e010863, 2023. doi: 10.1136/bmjgh-2022-010863.
4. N. A. Turner et al., "Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research," Nature Reviews Microbiology, vol. 17, no. 4, pp. 203-218, 2019. doi: 10.1038/s41579-018-0147-4.
5. R. Urban-Chmiel et al., "Antibiotic resistance in bacteria—A review," Antibiotics, vol. 11, no. 8, p. 1079, 2022. doi: 10.3390/antibiotics11081079.
6. R. Parastan, M. Kargar, K. Solhjoo, and F. Kafilzadeh, "Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines," Gene Reports, vol. 20, p. 100739, 2020. doi.org/10.1016/j.genrep.2020.100739.
7. N. A. Rasheed and N. R. Hussein, "Staphylococcus aureus: an overview of discovery, characteristics, epidemiology, virulence factors and antimicrobial sensitivity," European Journal of Molecular & Clinical Medicine, vol. 8, no. 3, pp. 1160-1183, 2021.
8. P. Nikolic and P. Mudgil, "The cell wall, cell membrane and virulence factors of Staphylococcus aureus and their role in antibiotic resistance," Microorganisms, vol. 11, no. 2, p. 259, 2023. doi: 10.3390/microorganisms11020259.
9. A. Hrynyshyn, M. Simões, and A. Borges, "Biofilms in surgical site infections: recent advances and novel prevention and eradication strategies," Antibiotics, vol. 11, no. 1, p. 69, 2022. doi: 10.3390/antibiotics11010069.
10. S. Dewasthale, I. Mani, and K. Vasdev, "Microbial biofilm: current challenges in health care industry," J Appl Biotechnol Bioeng, vol. 5, no. 3, pp. 160-164, 2018. doi: 10.15406/jabb.2018.05.00132.
11. J.-Y. Maillard and I. Centeleghe, "How biofilm changes our understanding of cleaning and disinfection," Antimicrobial Resistance & Infection Control, vol. 12, no. 1, p. 95, 2023. doi: 10.1186/s13756-023-01290-4.
12. M. A. Díaz, E. G. Vega-Hissi, M. A. Blázquez, M. R. Alberto, and M. E. Arena, "Restraining Staphylococcus aureus virulence factors and quorum sensing through lactic acid bacteria supernatant extracts," Antibiotics, vol. 13, no. 4, p. 297, 2024. doi: 10.3390/antibiotics13040297.
13. G. Pietrocola, D. Campoccia, C. Motta, L. Montanaro, C. R. Arciola, and P. Speziale, "Colonization and infection of indwelling medical devices by Staphylococcus aureus with an emphasis on orthopedic implants," International journal of molecular sciences, vol. 23, no. 11, p. 5958, 2022. doi: 10.3390/ijms23115958.
14. E. E. Hegazy et al., "Study of Class 1, 2, and 3 Integrons, Antibiotic Resistance Patterns, and Biofilm Formation in Clinical Staphylococcus aureus Isolates from Hospital-Acquired Infections," Pathogens, vol. 14, no. 7, p. 705, 2025. doi: 10.3390/pathogens14070705.
15. M. CLSI "Performance standards for antimicrobial susceptibility testing," ed: CLSI, Wayne, PA USA, 2019.
16. U. Gaire et al., "Antibiotic susceptibility, biofilm production, and detection of mec A gene among Staphylococcus aureus isolates from different clinical specimens," Diseases, vol. 9, no. 4, p. 80, 2021. doi: 10.3390/diseases9040080.
17. E. Z. Gebremedhin et al., "Isolation and identification of Staphylococcus aureus from milk and milk products, associated factors for contamination, and their antibiogram in Holeta, Central Ethiopia," Veterinary Medicine International, vol. 2022, no. 1, p. 6544705, 2022. doi: 10.1155/2022/6544705.
18. M. Preda et al., "Phenotypic and genotypic virulence features of staphylococcal strains isolated from difficult-to-treat skin and soft tissue infections," PLoS One, vol. 16, no. 2, p. e0246478, 2021. doi: 10.1371/journal.pone.0246478.
19. K. Reiner, "Catalase test protocol. American Society for Microbiolog, Washington," DC, USA, vol. 1, p. 6, 2010.
20. P. Shields and L. Cathcart, "Oxidase test protocol. American Society for Microbiology," Link: https://bit. ly/3tpubGp, 2010.
21. D. Martinvalet and M. Walch, "The role of reactive oxygen species in protective immunity," vol. 12, ed: Frontiers Media SA, 2022, p. 832946. doi: 10.3389/fimmu.2021.832946.
22. N. Rasheed and N. R. Hussein, "The nasal carriage of Staphylococcus aureus and its antimicrobial susceptibility pattern in secondary school students in Kurdistan region, Iraq," 2020.
23. S. S. AL-Salihi, G. F. Karim, A. Al-Bayati, and H. M. Obaid, "Prevalence of Methicillin-Resistant and Methicillin Sensitive Staphylococcus aureus Nasal Carriage and their Antibiotic Resistant Patterns in Kirkuk City, Iraq," Journal of Pure & Applied Microbiology, vol. 17, no. 1, 2023. doi: 10.22207/JPAM.17.1.22.
24. B. P. Howden et al., "Staphylococcus aureus host interactions and adaptation," Nature Reviews Microbiology, vol. 21, no. 6, pp. 380-395, 2023. doi: 10.1038/s41579-023-00852-y.
25. S. D. Brugger, L. Bomar, and K. P. Lemon, "Commensal–pathogen interactions along the human nasal passages," PLoS pathogens, vol. 12, no. 7, p. e1005633, 2016. doi: 10.1371/journal.ppat.1005633.
26. F. Weldegebreal et al., "Nasal carriage rate, associated factors, and antimicrobial susceptibility patterns of methicillin resistance Staphylococcus aureus among pre-clinical undergraduate students at the College of Health and Medical Sciences, Haramaya University, Ethiopia," Frontiers in Public Health, vol. 12, p. 1354461, 2024. doi: 10.3389/fpubh.2024.1354461.
27. M. Vestergaard, D. Frees, and H. Ingmer, "Antibiotic resistance and the MRSA problem," Microbiology spectrum, vol. 7, no. 2, pp. 10.1128/microbiolspec. gpp3-0057-2018, 2019. doi: 10.1128/microbiolspec.GPP3-0057-2018.
28. K. Schilcher and A. R. Horswill, "Staphylococcal biofilm development: structure, regulation, and treatment strategies," Microbiology and Molecular Biology Reviews, vol. 84, no. 3, pp. 10.1128/mmbr. 00026-19, 2020. doi: 10.1128/MMBR.00026-19.
29. I. Mack, M. Sharland, J. A. Berkley, N. Klein, S. Malhotra-Kumar, and J. Bielicki, "Antimicrobial resistance following azithromycin mass drug administration: potential surveillance strategies to assess public health impact," Clinical Infectious Diseases, vol. 70, no. 7, pp. 1501-1508, 2020. doi: 10.1093/cid/ciz893.
30. L. K. Muhammed and A. J. Saleem, "Study of Antibiotics Resistance and Biofilm Formation of Staphylococcus aureus," Al-Nisour Journal for Medical Sciences, vol. 6, no. 1, pp. 60-71, 2024. doi.org/10.70492/2664-0554.1122.
31. N. A.-S. Ramadan and K. I. Mubarak, "Bacteriology and epidemiology study for nasal carriage Staphylococcus aureus in Baquba," Biochemical & Cellular Archives, vol. 20, no. 2, 2020.
32. Z. A. Hatem, H. R. R. Al-Taai, and A. A. F. Al-Dulaimi, "Molecular investigation of some erythromycin resistance genes in Staph aureus isolated from different clinical infections in Diyala, Iraq," 2021.
33. R. Z. T. Ahmed and R. M. Abdullah, "Detection of integron classes and agr group in Staphylococcus aureus isolated from different clinical samples," Ibn AL-Haitham Journal For Pure and Applied Sciences, vol. 37, no. 2, pp. 111-127, 2024. doi.org/10.30526/37.2.3419.
34. Z. Hemmati, F. Bazrafshan, B. Jahan Latibari, P. Mehrpour Ghaziani, and M. Hashemi Khou, "Study on the prevalence of methicillin-resistant Staphylococcus aureus infection, antibiotic resistance pattern, biofilms genes, and antibiotic resistance genes from clinical samples," Archives of Razi Institute, vol. 79, no. 5, p. 923, 2024. doi: 10.32592/ARI.2024.79.5.923.
35. C. H. Chew et al., "Multidrug-resistant methicillin-resistant Staphylococcus aureus associated with hospitalized newborn infants," Diagnostics, vol. 13, no. 6, p. 1050, 2023. doi: 10.3390/diagnostics13061050.
36. X. Wu et al., "Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeutics," Biofilm, vol. 7, p. 100175, 2024. doi: 10.1016/j.bioflm.2023.100175.
37. N. Z. AlKhazraji, A. S. Al Jubouri, and M. F. Al Ma, "Detection of antiseptic resistant genes and biofilm formation in multidrug resistant Staphylococcus aureus in baghdad hospitals," Iraqi journal of biotechnology, vol. 19, no. 2, 2020.
38. Z. A. Hatem, S. A. Jasim, and Z. H. Mahdi, "Phenotypic and genotypic characterization of antibiotic resistance in Staphylococcus aureus isolated from different sources," 2021. doi: 10.5812/jjm.115221.
39. F. Lamret et al., "Staphylococcus aureus strain-dependent biofilm formation in bone-like environment," Frontiers in Microbiology, vol. 12, p. 714994, 2021. doi: 10.3389/fmicb.2021.714994.
40. M. G. Avila-Novoa et al., "Genetic and compositional analysis of biofilm formed by Staphylococcus aureus isolated from food contact surfaces," Frontiers in Microbiology, vol. 13, p. 1001700, 2022. doi: 10.3389/fmicb.2022.1001700.
41. H. Y. Liu, E. L. Prentice, and M. A. Webber, "Mechanisms of antimicrobial resistance in biofilms," npj Antimicrobials and Resistance, vol. 2, no. 1, p. 27, 2024. doi: 10.1038/s44259-024-00046-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 CC BY 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
